ADTX
Aditxt Inc.
NASDAQ: ADTX · HEALTHCARE · BIOTECHNOLOGY
$0.22
-0.73% today
Updated 2026-04-29
Market cap
$196180.00
P/E ratio
—
P/S ratio
61.40x
EPS (TTM)
$-9,230.64
Dividend yield
—
52W range
$0 – $2,495
Volume
1.8M
Aditxt Inc. (ADTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-386263.00 | $-386263.00 | $-464352.00 | $-7.22M | $-22.28M | $-22.39M | $-18.58M | $-16.76M | $-25.69B |
| Capital expenditures | $170629.00 | $170629.00 | $170629.00 | $170629.00 | $1.02M | $367079.00 | $14407.00 | $0.00 | $13.74M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $612344.00 | $3.52M | $4.23M | $3.19M | $4.64M | $3.13M | $1.40M | $6.75M | $473.31M |
| Free cash flow | $-556892.00 | $-556892.00 | $-634981.00 | $-7.39M | $-23.29M | $-22.76M | $-18.59M | $-16.76M | $-25.70B |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |